http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001504706-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-472 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
filingDate | 1997-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2001-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2001504706-A |
titleOfInvention | Complement inhibitor |
abstract | (57) [Summary]nThe present invention relates to the regulation of complement activation, in particular, to the liquid phase regulation of complement activation, and relates to a molecule containing at least the complement control protein modules 1 to 4 of complement factor H, a molecule encoding the same, and a complement. The invention provides a method for the manufacture of a medicament for inhibiting the activation of the same and its use in a method of manufacture, a DNA sequence encoding rat FH 4.3 and 1.0 kb mRNA. |
priorityDate | 1996-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 818.